The role of inflammation on atherosclerosis

May 1, 2012, CORDIS

(Medical Xpress) -- European scientists dig into atherosclerotic plaque formation processes to investigate the part played by inflammation and vascular wall remodelling.

Cardiovascular diseases remain a serious health problem necessitating an understanding of the underlying mechanisms and the development of novel diagnostic, preventive and therapeutic strategies. Atherosclerosis is caused by a thickening of the capillary walls due to accumulation of lipids such as cholesterol.

Accumulating evidence indicates that inflammation plays a central role in atherosclerosis. To further delineate the causes of atherosclerosis, the EU-funded Atheroremo project has brought together scientists from an array of disciplines.

Project partners have identified some previously unknown involved in vascular inflammation. Their discovery of a novel role of the Streptococcus mitis in atherosclerosis demonstrates that infection can act as a potential initiator of disease. By dissecting the atherosclerotic plaque, researchers have noticed that expression of inflammatory interferons induces changes in the lining the arteries inducing vascular remodelling. A further intriguing discovery has been the involvement of anti-lipoprotein antibodies in atherosclerosis.

Additionally, the consortium has tested a number of novel treatments including montelukast – a compound used in asthma medication – to prevent arterial wall remodelling. Various anti-inflammatory compounds are currently being tried as potential therapeutic strategies.

The Atheroremo project has also joined a large clinical analysis study of patient genetics to discover several new biomarkers for atherosclerosis risk. These novel predictive lipid molecules will form the basis for patient risk assessment.

Overall, the study results to date provide significant information on the inflammatory mechanisms governing atherosclerotic . This knowledge is expected to have serious implications in the diagnosis and therapy of atherosclerosis patients.

Related Stories

Recommended for you

Researchers devise decoy molecule to block pain where it starts

January 16, 2018
For anyone who has accidentally injured themselves, Dr. Zachary Campbell not only sympathizes, he's developing new ways to blunt pain.

Scientists unleash power of genetic data to identify disease risk

January 16, 2018
Massive banks of genetic information are being harnessed to shed new light on modifiable health risks that underlie common diseases.

Blood-vessel-on-a-chip provides insight into new anti-inflammatory drug candidate

January 15, 2018
One of the most important and fraught processes in the human body is inflammation. Inflammatory responses to injury or disease are crucial for recruiting the immune system to help the body heal, but inflammation can also ...

Molecule produced by fat cells reduces obesity and diabetes in mice

January 15, 2018
UC San Francisco researchers have discovered a new biological pathway in fat cells that could explain why some people with obesity are at high risk for metabolic diseases such as type 2 diabetes. The new findings—demonstrated ...

Obese fat becomes inflamed and scarred, which may make weight loss harder

January 12, 2018
The fat of obese people becomes distressed, scarred and inflamed, which can make weight loss more difficult, research at the University of Exeter has found.

Optimized human peptide found to be an effective antibacterial agent

January 11, 2018
A team of researchers in the Netherlands has developed an effective antibacterial ointment based on an optimized human peptide. In their paper published in the journal Science Translational Medicine, the group describes developing ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.